Jennifer Foulke-Abel1, Julie In1, Jianyi Yin1, Nicholas C Zachos1, Olga Kovbasnjuk1, Mary K Estes2, Hugo de Jonge3, Mark Donowitz4. 1. Department of Medicine, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas. 3. Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. 4. Department of Medicine, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: mdonowit@jhmi.edu.
Abstract
BACKGROUND & AIMS: Human intestinal crypt-derived enteroids are a model of intestinal ion transport that require validation by comparison with cell culture and animal models. We used human small intestinal enteroids to study neutral Na(+) absorption and stimulated fluid and anion secretion under basal and regulated conditions in undifferentiated and differentiated cultures to show their functional relevance to ion transport physiology and pathophysiology. METHODS: Human intestinal tissue specimens were obtained from an endoscopic biopsy or surgical resections performed at Johns Hopkins Hospital. Crypts were isolated, enteroids were propagated in culture, induced to undergo differentiation, and transduced with lentiviral vectors. Crypt markers, surface cell enzymes, and membrane ion transporters were characterized using quantitative reverse-transcription polymerase chain reaction, immunoblot, or immunofluorescence analyses. We used multiphoton and time-lapse confocal microscopy to monitor intracellular pH and luminal dilatation in enteroids under basal and regulated conditions. RESULTS: Enteroids differentiated upon withdrawal of WNT3A, yielding decreased crypt markers and increased villus-like characteristics. Na(+)/H(+) exchanger 3 activity was similar in undifferentiated and differentiated enteroids, and was affected by known inhibitors, second messengers, and bacterial enterotoxins. Forskolin-induced swelling was completely dependent on cystic fibrosis transmembrane conductance regulator and partially dependent on Na(+)/H(+) exchanger 3 and Na(+)/K(+)/2Cl(-) cotransporter 1 inhibition in undifferentiated and differentiated enteroids. Increases in cyclic adenosine monophosphate with forskolin caused enteroid intracellular acidification in HCO3(-)-free buffer. Cyclic adenosine monophosphate-induced enteroid intracellular pH acidification as part of duodenal HCO3(-) secretion appears to require cystic fibrosis transmembrane conductance regulator and electrogenic Na(+)/HCO3(-) cotransporter 1. CONCLUSIONS: Undifferentiated or crypt-like, and differentiated or villus-like, human enteroids represent distinct points along the crypt-villus axis; they can be used to characterize electrolyte transport processes along the vertical axis of the small intestine. The duodenal enteroid model showed that electrogenic Na(+)/HCO3(-) cotransporter 1 might be a target in the intestinal mucosa for treatment of secretory diarrheas.
BACKGROUND & AIMS:Human intestinal crypt-derived enteroids are a model of intestinal ion transport that require validation by comparison with cell culture and animal models. We used human small intestinal enteroids to study neutral Na(+) absorption and stimulated fluid and anion secretion under basal and regulated conditions in undifferentiated and differentiated cultures to show their functional relevance to ion transport physiology and pathophysiology. METHODS:Human intestinal tissue specimens were obtained from an endoscopic biopsy or surgical resections performed at Johns Hopkins Hospital. Crypts were isolated, enteroids were propagated in culture, induced to undergo differentiation, and transduced with lentiviral vectors. Crypt markers, surface cell enzymes, and membrane ion transporters were characterized using quantitative reverse-transcription polymerase chain reaction, immunoblot, or immunofluorescence analyses. We used multiphoton and time-lapse confocal microscopy to monitor intracellular pH and luminal dilatation in enteroids under basal and regulated conditions. RESULTS: Enteroids differentiated upon withdrawal of WNT3A, yielding decreased crypt markers and increased villus-like characteristics. Na(+)/H(+) exchanger 3 activity was similar in undifferentiated and differentiated enteroids, and was affected by known inhibitors, second messengers, and bacterial enterotoxins. Forskolin-induced swelling was completely dependent on cystic fibrosis transmembrane conductance regulator and partially dependent on Na(+)/H(+) exchanger 3 and Na(+)/K(+)/2Cl(-) cotransporter 1 inhibition in undifferentiated and differentiated enteroids. Increases in cyclic adenosine monophosphate with forskolin caused enteroid intracellular acidification in HCO3(-)-free buffer. Cyclic adenosine monophosphate-induced enteroid intracellular pH acidification as part of duodenal HCO3(-) secretion appears to require cystic fibrosis transmembrane conductance regulator and electrogenic Na(+)/HCO3(-) cotransporter 1. CONCLUSIONS: Undifferentiated or crypt-like, and differentiated or villus-like, human enteroids represent distinct points along the crypt-villus axis; they can be used to characterize electrolyte transport processes along the vertical axis of the small intestine. The duodenal enteroid model showed that electrogenic Na(+)/HCO3(-) cotransporter 1 might be a target in the intestinal mucosa for treatment of secretory diarrheas.
Authors: Lara R Gawenis; Emily M Bradford; Vikram Prasad; John N Lorenz; Janet E Simpson; Lane L Clarke; Alison L Woo; Christina Grisham; L Philip Sanford; Thomas Doetschman; Marian L Miller; Gary E Shull Journal: J Biol Chem Date: 2006-12-27 Impact factor: 5.157
Authors: Jennifer Foulke-Abel; Julie In; Olga Kovbasnjuk; Nicholas C Zachos; Khalil Ettayebi; Sarah E Blutt; Joseph M Hyser; Xi-Lei Zeng; Sue E Crawford; James R Broughman; Mary K Estes; Mark Donowitz Journal: Exp Biol Med (Maywood) Date: 2014-04-09
Authors: Lara R Gawenis; Craig L Franklin; Janet E Simpson; Bradley A Palmer; Nancy M Walker; Tarra M Wiggins; Lane L Clarke Journal: Gastroenterology Date: 2003-10 Impact factor: 22.682
Authors: Marina N Chernova; Lianwei Jiang; Boris E Shmukler; Clifford W Schweinfest; Paola Blanco; Steven D Freedman; Andrew K Stewart; Seth L Alper Journal: J Physiol Date: 2003-03-21 Impact factor: 5.182
Authors: Onur Cil; Puay-Wah Phuan; Jung-Ho Son; Jie S Zhu; Colton K Ku; Niloufar Akhavan Tabib; Andrew P Teuthorn; Loretta Ferrera; Nicholas C Zachos; Ruxian Lin; Luis J V Galietta; Mark Donowitz; Mark J Kurth; Alan S Verkman Journal: Transl Res Date: 2016-10-15 Impact factor: 7.012
Authors: Jennifer Barrila; Aurélie Crabbé; Jiseon Yang; Karla Franco; Seth D Nydam; Rebecca J Forsyth; Richard R Davis; Sandhya Gangaraju; C Mark Ott; Carolyn B Coyne; Mina J Bissell; Cheryl A Nickerson Journal: Infect Immun Date: 2018-10-25 Impact factor: 3.441
Authors: Joana F S Pereira; Nikhil T Awatade; Cláudia A Loureiro; Paulo Matos; Margarida D Amaral; Peter Jordan Journal: Cell Mol Life Sci Date: 2016-05-04 Impact factor: 9.261
Authors: Amanda M Pattison; Erik S Blomain; Dante J Merlino; Fang Wang; Mary Ann S Crissey; Crystal L Kraft; Jeff A Rappaport; Adam E Snook; John P Lynch; Scott A Waldman Journal: Infect Immun Date: 2016-09-19 Impact factor: 3.441
Authors: Diego F Niño; Chhinder P Sodhi; Charlotte E Egan; Qinjie Zhou; Joyce Lin; Peng Lu; Yukihiro Yamaguchi; Hongpeng Jia; Laura Y Martin; Misty Good; William B Fulton; Thomas Prindle; John A Ozolek; David J Hackam Journal: Shock Date: 2017-01 Impact factor: 3.454
Authors: Adilene Olvera; Hannah Carter; Anubama Rajan; Lily G Carlin; Xiaomin Yu; Xi-Lei Zeng; Samuel Shelburne; Micah Bhatti; Sarah E Blutt; Noah F Shroyer; Robert Jenq; Mary K Estes; Anthony Maresso; Pablo C Okhuysen Journal: Clin Infect Dis Date: 2021-05-18 Impact factor: 9.079